SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

FMC Corp. is an agricultural sciences company, which engages in the provision of solutions to growers and development of pipeline in crop protection, plant health, agriculture, pest control, and turf management. It offers insect control products under the Rynaxypyr and Cyazypyr brands. The company was founded by John Bean in 1883 and is headquartered in Philadelphia, PA.

FMC Corp.

FMCs sharply reduced third-quarter outlook, tied to weak demand, excess distributor inventory and major pricing resets, is driving the discussion and steep selloff. Traders are split between fears that heavy debt and continued operating weakness could lead to restructuring or bankruptcy, and hopes that the painful reset clears the way for a turnaround or short-covering bounce.

Rolls-Royce Holdings Plc designs, develops, manufactures, and services integrated power systems for use in the air, on land, and at sea. The company operates its business through following segments: Civil Aerospace, Power Systems, and Defense. The Civil Aerospace segment offers commercial aero engines and aftermarket services. The Power Systems segment includes engines, power systems and nuclear systems for civil power generation. The Defense segment consists of military aero engines, naval engines, submarines and aftermarket services. The company was founded in March 1906 and is headquartered in London, the United Kingdom.

Rolls-Royce Holdings Plc - ADR

Safrans comments about softer widebody-traffic growth are being cited as the main trigger for sector selling that has pulled Rolls-Royce lower, alongside broader concern about rising oil and jet-fuel costs. Many traders view the decline as an overreaction because Rolls-Royce has not reported a deterioration in its business, while others worry higher fuel costs could eventually reduce engine flying hours.

Helus Pharma, Inc. operates as a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental health conditions. It is currently developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated DMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds. The company was founded by Paul Glavine, Eric So, and John Kanakis on October 13, 2016 and is headquartered in Toronto, Canada.

Helus Pharma Inc.

Attention centers on Helus Pharmas pivotal Phase 3 HLP003 readout for adjunctive treatment of major depressive disorder, with traders focused on whether the trial can confirm earlier Phase 2 results. Sentiment is divided between optimism about the treatments potential and concern about binary trial risk, dilution, and recent share-price weakness.

TTM Technologies, Inc. engages in the manufacture and sale of printed circuit boards and backplane assemblies. It operates through the following segments: Aerospace and Defense (A&D), Commercial, and Radio Frequency and Specialty (RF&S) Components. The A&D segment consists of Printed circuit boards (PCBs), value-added assemblies, microelectronics, RF and microwave components and assemblies, and integrated mission systems. The Commercial segment includes PCBs using customer-supplied engineering and design plans supporting customers in the automotive, medical, industrial, and instrumentation, networking, and data center computing end markets. The RF&S Components segment consists of TTM designed RF components for commercial customers in the telecommunications, industrial, and instrumentation markets. The company was founded on March 20, 1978 and is headquartered in Santa Ana, CA.

TTM Technologies Inc

TTM Technologies is rebounding after a sharp post-earnings selloff despite a strong quarter and upbeat outlook. Traders are weighing acquisition-related debt and execution concerns, along with supply-chain and project-timing issues, against continued AI data-center demand.

Fervo Energy Co. operates as a energy company. It builds and operates power facilities in extracting geothermal energy. The company was founded by Jack Norbeck and Timothy Latimer in 2017 and is headquartered in Berkeley, CA.

Fervo Energy Co. - Ordinary Shares - Class A

Fervo Energy Co

FRVO is drawing attention amid a sharp post-IPO decline and debate over a Morpheus short report questioning Fervos geothermal performance and commercial prospects. Bears cite water-loss, transmission and project-economics risks, while bulls dispute the report and point to Cape Stations first power and customer contracts as evidence of progress.

Snap, Inc. is a technology company, which engages in the provision of a visual messaging application that was created to help people communicate through short videos and images. The company was founded by Frank Reginald Brown IV, Evan Thomas Spiegel, and Robert C. Murphy in 2010 and is headquartered in Santa Monica, CA.

Snap Inc - Ordinary Shares - Class A

Snap Inc

A recent rebound and unusually heavy bullish call activity ahead of Q3 earnings are driving attention, with traders betting on improved advertising and cost savings as well as interest in Snaps Specs AR glasses and Robert Downey Jr. campaign. Bulls see a possible turnaround, while skeptics warn that the rally may fade and point to ongoing ad-market and competition concerns; buyout talk remains speculation.

Zoom Communications, Inc. engages in the provision of a communications and collaboration platform. It operates through the following geographical segments: Americas, Asia Pacific, and Europe, Middle East, and Africa. The company was founded by Eric S. Yuan in 2011 and is headquartered in San Jose, CA.

Zoom Communications Inc. - Ordinary Shares - Class A

Oppenheimers upgrade to Outperform, citing stronger-than-expected uptake of Zooms AI platform, is drawing bullish attention to the companys AI-driven growth story. Traders are positioning for a rebound, while skeptics question whether AI momentum can overcome modest growth and competition from Microsoft and Google.

Coherent Corp. engages in the development, refinement, manufacturing, and marketing of engineered materials, opto-electronic components and devices, and lasers for use in the industrial, communications, electronics, and instrumentation markets. It operates through the following segments: Networking, Materials, and Lasers. The Networking segment leverages compound semiconductor technology platforms and deep knowledge of end-user applications. The Materials segment markets engineered materials and optoelectronic devices. The Lasers segment serves industrial customers in semiconductor capital equipment, display capital equipment, precision manufacturing, and aerospace and defense, as well as instrumentation customers in life sciences and scientific research. The company was founded by Carl J. Johnson in 1971 and is headquartered in Saxonburg, PA.

Coherent Corp

Coherent is caught in a broader selloff in AI optics and networking stocks, as traders worry that AI data-center spending may slow and valuations have compressed; the discussion points more to sector risk-off than a company-specific breakdown. Traders are split between expecting further weakness, especially if guidance disappoints, and treating the pullback as an opportunity based on ongoing demand for optical connectivity.

Chevron Corp. engages in the provision of oil and gas energy solutions. It provides crude oil and natural gas, manufactures transportation fuels, lubricants, petrochemicals, and additives, and develops technologies that enhance business and the industry. It operates through the Upstream and Downstream segments. The Upstream segment consists of the exploration, development, and production of crude oil and natural gas, the liquefaction, transportation, and regasification associated with liquefied natural gas, the transporting of crude oil by major international oil export pipelines, the processing, transporting, storage, and marketing of natural gas, and a gas-to-liquids plant. The Downstream segment consists of the refining of crude oil into petroleum products, the marketing of crude oil and refined products, the transporting of crude oil and refined products by pipeline, marine vessel, motor equipment, and rail car, and the manufacturing and marketing of commodity petrochemicals and plastics for industrial uses and fuel & lubricant additives. The company was founded on September 10, 1879 and is headquartered in Houston, TX.

Chevron Corp.

Chevrons breakout to record highs is drawing attention as crude prices rise amid Strait of Hormuz supply concerns, with traders also positioning ahead of the upcoming earnings report. Sentiment is broadly bullish on oil and momentum, though some caution that expectations have risen and the report could test the rally.

Algorand is a scalable, secure, and decentralized digital currency and smart contract platform. Its protocol uses a variation of Proof-of-Stake (PoS) called Pure PoS (PPoS) to secure the network and reach consensus on block production. Developers can build decentralized applications (dApps) using familiar programming languages, including Python, which Algorand supports natively. Its infrastructure enables various use cases, including payment systems, digital identity solutions, supply-chain tracking, and financial services. The protocol's architecture allows for tokenization of assets and the development of smart contracts, while its technical specifications support both retail users seeking basic transaction capabilities and enterprises requiring more, complex, blockchain solutions.

Algorand

A volatile recovery from recent lows and continued resistance around key chart levels are driving discussion, with bullish traders expecting an altcoin-cycle rebound while bears stress ALGOs prolonged decline and repeated failed rallies. Supporters also point to Algorands post-quantum features and AI-agent payment activity as potential sources of longer-term utility, though traders disagree on whether those developments will translate into stronger price action.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Clearmind Medicine, Inc. is a psychedelic pharmaceutical biotech company. It focuses on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize it as regulated medicines, foods, or supplements. The company was founded on July 18, 2017 and is headquartered in Vancouver, Canada.

Clearmind Medicine Inc

Neutral Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Current Price	$5.87
Prev Close	$6.00
Open	$6.26
Dividend Yield	0.00%
50-Day Moving Average	$8.97
Beta	0.61
Avg. Volume	136,311.19
PE Ratio	-0.07

52-Week High	$3,840.00
52-Week Low	$5.25
Market Capitalization	$2.98M
EPS (Annual)	-$303.48
Price to Book	0.97
Revenue Per Employee	N/A

Feed

News

Sentiment

Fundamentals

Info

CMNDF Fundamentals